Trials / Completed
CompletedNCT02833077
A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 221 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is a safety and effectiveness study of JUVÉDERM VOLUMA XC injectable gel for chin augmentation to correct volume deficit in chin retrusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JUVÉDERM VOLUMA® XC | JUVÉDERM VOLUMA® XC was injected into the chin at a volume determined by the investigator. The maximum total volume administered was up to 4 mL. |
Timeline
- Start date
- 2016-06-28
- Primary completion
- 2018-02-06
- Completion
- 2018-10-11
- First posted
- 2016-07-14
- Last updated
- 2020-07-23
- Results posted
- 2020-07-23
Locations
14 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02833077. Inclusion in this directory is not an endorsement.